Patent And Know-How License Agreement Sample Contracts

Novan, Inc. – Novan Patent and Know-How License Agreement (August 24th, 2016)

THIS NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement) is made as of December 29, 2015 (the Effective Date) by and between Novan, Inc., a Delaware corporation with a principal place of business at 4222 Emperor Boulevard, Suite 200, Durham, NC 27703 (Novan), and KNOW Bio, LLC, a North Carolina limited liability company with a principal place of business at 627 Davis Drive, Suite 400, Morrisville, NC 27560 (Licensee). Novan and Licensee may each be referred to as a Party, and together as the Parties.

Novan, Inc. – Novan Patent and Know-How License Agreement (February 1st, 2016)

THIS NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement) is made as of December 29, 2015 (the Effective Date) by and between Novan, Inc., a Delaware corporation with a principal place of business at 4222 Emperor Boulevard, Suite 200, Durham, NC 27703 (Novan), and KNOW Bio, LLC, a North Carolina limited liability company with a principal place of business at 627 Davis Drive, Suite 400, Morrisville, NC 27560 (Licensee). Novan and Licensee may each be referred to as a Party, and together as the Parties.

Cerecor Inc. – Exclusive Patent and Know-How License Agreement (June 12th, 2015)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement), effective as of March 19, 2013 (the Effective Date), is by and between Essex Chemie AG, a Swiss corporation, having a principal place of business at Weystrasse 20, 6000 Lucerne 6, Switzerland (Merck), and Cerecor Inc. (Cerecor), a corporation organized and existing under the laws of Delaware (hereinafter referred to as Licensee). Merck and Licensee are sometimes referred to herein individually as a Party and collectively as the Parties.

Cerecor Inc. – Exclusive Patent and Know How License Agreement (June 12th, 2015)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this "Agreement"), effective as of this 18th day of February, 2015 (the "Effective Date"), is by and between Eli Lilly and Company ("Lilly"), and Cerecor Inc. ("Cerecor"), a corporation organized and existing under the laws of Delaware (hereinafter referred to as "Licensee"). Lilly and Licensee are sometimes referred to herein individually as a "Party" and collectively as the "Parties".

Cerecor Inc. – Exclusive Patent and Know-How License Agreement (June 12th, 2015)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement), effective as of March 19, 2013 (the Effective Date), is by and between Essex Chemie AG, a Swiss corporation, having a principal place of business at Weystrasse 20, 6000 Lucerne 6, Switzerland (Merck), and Cerecor Inc. (Cerecor), a corporation organized and existing under the laws of Delaware (hereinafter referred to as Licensee). Merck and Licensee are sometimes referred to herein individually as a Party and collectively as the Parties.

Cerecor Inc. – Exclusive Patent and Know How License Agreement (April 29th, 2015)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this "Agreement"), effective as of this 18th day of February, 2015 (the "Effective Date"), is by and between Eli Lilly and Company ("Lilly"), and Cerecor Inc. ("Cerecor"), a corporation organized and existing under the laws of Delaware (hereinafter referred to as "Licensee"). Lilly and Licensee are sometimes referred to herein individually as a "Party" and collectively as the "Parties".

Patent and Know How License Agreement (November 4th, 2014)

THIS AGREEMENT, effective as of the 30th day of October, 2014, by and between KIMBERLY-CLARK WORLDWIDE, INC., a Delaware corporation (KCWW or Licensor), and AVENT, INC., a Delaware corporation (Avent or Licensee).

Patent and Know How License Agreement (September 22nd, 2014)

THIS AGREEMENT, effective as of the day of , 2014, by and between KIMBERLY-CLARK WORLDWIDE, INC., a Delaware corporation (KCWW or Licensor), and AVENT, INC., a Delaware corporation (Avent or Licensee).

Cerecor Inc. – Exclusive Patent and Know-How License Agreement (April 21st, 2014)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement), effective as of March 19, 2013 (the Effective Date), is by and between Essex Chemie AG, a Swiss corporation, having a principal place of business at Weystrasse 20, 6000 Lucerne 6, Switzerland (Merck), and Cerecor Inc. (Cerecor), a corporation organized and existing under the laws of Delaware (hereinafter referred to as Licensee). Merck and Licensee are sometimes referred to herein individually as a Party and collectively as the Parties.

Cerecor Inc. – Exclusive Patent and Know-How License Agreement (April 21st, 2014)

THIS EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT (this Agreement), effective as of March 19, 2013 (the Effective Date), is by and between Essex Chemie AG, a Swiss corporation, having a principal place of business at Weystrasse 20, 6000 Lucerne 6, Switzerland (Merck), and Cerecor Inc. (Cerecor), a corporation organized and existing under the laws of Delaware (hereinafter referred to as Licensee). Merck and Licensee are sometimes referred to herein individually as a Party and collectively as the Parties.

Bluebird Bio Inc. – Contract (May 21st, 2013)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Bluebird Bio Inc. – Contract (May 14th, 2013)

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Patent and Know-How License Agreement (The Company as Licensor) (March 28th, 2013)

THIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the "Agreement") is made effective as of February 6, 2013 (the "Effective Date"), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 ("Pfizer") and Zoetis Inc., a Delaware corporation having its principal place of business at 5 Giralda Farms, Madison, NJ 07940 (the "Company"). Pfizer and the Company are sometimes referred to herein individually as a "Party" and collectively as the "Parties."

Patent and Know-How License Agreement (March 28th, 2013)

THIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the "Agreement") is made effective as of February 6, 2013 (the "Effective Date"), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 ("Pfizer") and Zoetis Inc., a Delaware corporation having its principal place of business at 5 Giralda Farms, Madison, NJ 07940 (the "Company"). Pfizer and the Company are sometimes referred to herein individually as a "Party" and collectively as the "Parties."

Form of Patent and Know-How License Agreement (Pfizer as Licensor) (January 11th, 2013)

This PATENT AND KNOW-HOW LICENSE AGREEMENT (the Agreement) is made effective as of [] (the Effective Date), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (Pfizer) and Zoetis Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (the Company). Pfizer and the Company are sometimes referred to herein individually as a Party and collectively as the Parties.

Form of Patent and Know-How License Agreement (The Company as Licensor) (November 9th, 2012)

This PATENT AND KNOW-HOW LICENSE AGREEMENT (the Agreement) is made effective as of [] (the Effective Date), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (Pfizer) and Zoetis Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (the Company). Pfizer and the Company are sometimes referred to herein individually as a Party and collectively as the Parties.

Form of Patent and Know-How License Agreement (Pfizer as Licensor) (November 9th, 2012)

This PATENT AND KNOW-HOW LICENSE AGREEMENT (the Agreement) is made effective as of [] (the Effective Date), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (Pfizer) and Zoetis Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (the Company). Pfizer and the Company are sometimes referred to herein individually as a Party and collectively as the Parties.

See Attached File "Patent and Know-How License Agreement" (October 18th, 2010)
NEXX Systems – Patent and Know-How License Agreement (April 6th, 2010)

This AGREEMENT dated as of August 7, 2001 made by and between Applied Science and Technology, Inc., a Delaware corporation having a principal place of business at 90 Industrial Way, Wilmington, Massachusetts, 01887 ("AST") and ASTeX PlasmaQuest Inc., a corporation of Texas having a principal place of business at 12024 Forestgate Drive, Dallas Texas 75243 ("PlasmaQuest") (AST and PlasmaQuest are collectively referred to as "Licensors"), on the one hand, and NEXX System LLC, a Delaware limited liability company corporation having its principal place of business at 90 Industrial Way, Wilmington, Massachusetts 01887-4610 ("NEXX"), on the other hand.

Exclusive Patent and Know How License Agreement by and Between Pharmasset, Ltd (Licensor) and Primagen Holding B.V. (Licensee) (April 24th, 2007)

Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets and asterisks [***], have been separately filed with the Commission.

Global Energy Holdings Group – Confidential Exclusive Patent and Know-How Final License Agreement Dated as of May 24, 2006 Between the Energy and Environmental Research Center Foundation and Advanced Biomass Gasification Technologies, Inc. ENERGY & ENVIRONMENTAL RESEARCH CENTER FOUNDATION EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT ON SMALL BIOMASS GASIFICATION (June 16th, 2006)

This Agreement, effective as of the date set forth above the signatures of the parties below (the "EFFECTIVE DATE"), is between the Energy & Environmental Research Center Foundation ("LICENSOR"), a nonprofit foundation incorporated under the laws of North Dakota, EERC Foundation, 15 North 23rd Street, PO Box 9018, Grand Forks, ND 58202-9018, and Advanced Biomass Gasification Technologies, Inc. (ABGT* ), a wholly owned subsidiary of UTEK Corporation ("LICENSEE"), a Florida corporation, with a principal place of business at 202 South Wheeler Street, Plant City, Florida 33563.

Exclusive Patent and Know How License Agreement by and Between Pharmasset, Ltd (Licensor) and Primagen Holding B.V. (Licensee) (May 8th, 2006)

Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets and asterisks [***], have been separately filed with the Commission.

Novacea – Patent and Know-How License Agreement (May 2nd, 2006)

THIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the Agreement) is executed on July 19, 2005 (the Effective Date) by and between PIERRE FABRE MEDICAMENT S.A., a corporation organized under the laws of France with headquarters at 45, place Abel-Gance, 921000 BOULOGNE, FRANCE (PIERRE FABRE) and NOVACEA, INC., a Delaware corporation with a principal place of business at 601 Gateway Boulevard, Suite 800, SOUTH SAN FRANCISCO, CALIFORNIA 94080, U.S.A. (NOVACEA).

Novacea – ADDENDUM No. 1 to the PATENT AND KNOW-HOW LICENSE AGREEMENT Between PIERRE FABRE MEDICAMENT S.A. And NOVACEA, Inc. Dated February 21, 2006 (March 28th, 2006)

This ADDENDUM No. 1 to the Patent and Know-How License Agreement effective as of February 21, 2006 (the ADDENDUM No. 1 Effective Date) is executed by and between PIERRE FABRE MEDICAMENT S.A., a corporation organized under the laws of France with headquarters at 45, place Abel-Gance, 92100 BOULOGNE, FRANCE (PIERRE FABRE), and, NOVACEA, INC., a Delaware corporation with a principal place of business at 601 Gateway Boulevard, Suite 800, SOUTH SAN FRANCISCO, CALIFORNIA 94080, U.S.A. (NOVACEA).

Novacea – Patent and Know-How License Agreement (February 10th, 2006)

THIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the Agreement) is executed on July 19, 2005 (the Effective Date) by and between PIERRE FABRE MEDICAMENT S.A., a corporation organized under the laws of France with headquarters at 45, place Abel-Gance, 921000 BOULOGNE, FRANCE (PIERRE FABRE) and NOVACEA, INC., a Delaware corporation with a principal place of business at 601 Gateway Boulevard, Suite 800, SOUTH SAN FRANCISCO, CALIFORNIA 94080, U.S.A. (NOVACEA).

Dynamic Leisure Corporation – Exclusive Patent and Know-How License Agreement (January 23rd, 2006)

THIS AGREEMENT is made by and between Thomas C. Edwards, PhD, residing at 1426 Gleneagles Way, Rockledge, FL 32955 (hereinafter sometimes Edwards), and DynEco Corporation, a Minnesota corporation, having offices at 564 International Place, Rockledge, FL 32955 (hereinafter sometimes DynEco).

Aixtron Se – The Marked Portions of This Document Have Been Redacted and Filed Separately With the Commission Pursuant to Rule 406 of the Securities Act of 1933, as Amended EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT Ndeg L02130 (February 8th, 2005)
Aixtron Se – The Marked Portions of This Document Have Been Redacted and Filed Separately With the Commission Pursuant to Rule 406 of the Securities Act of 1933, as Amended EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT Ndeg L02130 (February 8th, 2005)
Lihir Gold, Limited – Patent and Know-How License Agreement (June 30th, 2004)

SHERRITT INC., an Ontario Corporation, having a business office at Fort Saskatchewan, Alberta, Canada (hereinafter called Sherritt);